| Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa T Togun, I Peterson, S Jaffar, F Oko, U Okomo, K Peterson, A Jaye AIDS Research and therapy 8, 1-8, 2011 | 53 | 2011 |
| Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia I Peterson, O Togun, T de Silva, F Oko, S Rowland-Jones, A Jaye, ... Aids 25 (17), 2167-2175, 2011 | 53 | 2011 |
| Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa U Okomo, T Togun, F Oko, K Peterson, J Townend, I Peterson, A Jaye BMC pediatrics 12, 1-11, 2012 | 35 | 2012 |
| Safety and immunogenicity of malaria vectored vaccines given with routine expanded program on immunization vaccines in Gambian infants and neonates: a randomized controlled trial VA Mensah, S Roetynck, EK Kanteh, G Bowyer, A Ndaw, F Oko, CM Bliss, ... Frontiers in immunology 8, 1551, 2017 | 31 | 2017 |
| Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa U Okomo, T Togun, F Oko, K Peterson, A Jaye AIDS research and therapy 9, 1-11, 2012 | 31 | 2012 |
| Use of self-reported adherence and keeping clinic appointments as predictors of viremia in routine HIV care in the Gambia K Peterson, J Menten, I Peterson, T Togun, U Okomo, F Oko, T Corrah, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2015 | 4 | 2015 |
